Current research team




















Former Post Doctoral Research Fellows




Carl Johan van der Westhuizen
2021
Development of automation protocols for use with flow reactors


Jabeena Khazir (Bilal Mir)
2014-15
Development and biological screening of novel anti-cancer agents
Former Doctoral Students




Nicole Candice Neyt
2020
Engineering reaction chemistry with flow technology: A discussion on method development and multi-step organic synthesis.




Carl Johan van der Westhuizen
2020
Combining in silico and in vitro approaches to discover novel inhibitors of acetylcholinesterase




Valerie Ramoatsoa
2020
The synthesis of immobilized reagents based on a polymerized triphenylphosphine scaffold for use in flow chemistry applications



Divan Gerald van Greunen
2019
The design, synthesis and biological evaluation of novel compounds against biomarkers of Alzheimer’s disease


Former Masters Students


Betty Kwati
2022
Investigating a semi-continuous synthetic pathway for the preparation of the antiretroviral drugs tenofovir disoproxil and tenofovir alafenamide


Sussan-Mari Botha
2021
The design and synthesis of potential acetylcholinesterase inhibitors and NMDA antagonists as neuroprotective agents





Sergio Lovisa
2020
The in silico evaluation and synthesis of silicon based analogues of the cholinesterase inhibitor Donepezil


Kgotso Moagi
2020
Reaction Mechanism of 2-monosubstituted Quinoxalines with Organolithium Compounds: A Theoretical Study



Lorinda Tarien van Wyk
2020
Utilization Of Flow Chemistry For The Syntheses Of Bupropion, Fluoxetine And Amitraz



Ansche Michelle Reinhardt
2020
The synthesis of analogues and bioisosteres of the acetylcholinesterase inhibitor donepezil in an attempt to identify novel anti-Alzheimer’s agents


Bryan Bulling
2018
Reaction mechanism of solvated n-BuLi with thiophene in THF: A theoretical and spectroscopic study








Carl Johan van der Westhuizen
2017
Nucleophilic reactions of α-haloketones: A computational study.



Bryan Bulling
2016
Targeting Alzheimer’s disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor Donepezil